A Pioneer in Minimally Invasive Prostate Cancer Treatment
Watch the video to hear our story
Preserving Quality of Life with Minimally Invasive Treatment Options
1 in 8 men will receive a prostate cancer diagnosis this year. Thousands will be told they have limited options, and that is not true.
HALO Diagnostics has been a pioneer in advancing minimally invasive prostate cancer treatment with reduced side effects. HALO provides a treatment pathway personalized for each individual prostate cancer or BPH diagnosis. Treatment options include:
- mpMRI prostate screenings to identify areas of suspicious tissue before an invasive biopsy.
- The HALO Diagnostics ensemble approach of mpMRI + PSAD + ExoDx misses 0% of clinically significant prostate cancer 13.5% of unnecessary biopsies are completely avoided.
- HALO offers two focal therapeutic treatment options:
- Laser Focal Therapy (LFT)
- TULSA-PRO®
Call 760-718-6353 or email us today!
